Cargando…

Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021

Detalles Bibliográficos
Autores principales: Kayki-Mutlu, Gizem, Aksoyalp, Zinnet Sevval, Wojnowski, Leszek, Michel, Martin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832083/
https://www.ncbi.nlm.nih.gov/pubmed/36335284
http://dx.doi.org/10.1007/s00210-022-02320-5
_version_ 1784867986527485952
author Kayki-Mutlu, Gizem
Aksoyalp, Zinnet Sevval
Wojnowski, Leszek
Michel, Martin C.
author_facet Kayki-Mutlu, Gizem
Aksoyalp, Zinnet Sevval
Wojnowski, Leszek
Michel, Martin C.
author_sort Kayki-Mutlu, Gizem
collection PubMed
description
format Online
Article
Text
id pubmed-9832083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98320832023-01-12 Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021 Kayki-Mutlu, Gizem Aksoyalp, Zinnet Sevval Wojnowski, Leszek Michel, Martin C. Naunyn Schmiedebergs Arch Pharmacol Correction Springer Berlin Heidelberg 2022-11-06 2023 /pmc/articles/PMC9832083/ /pubmed/36335284 http://dx.doi.org/10.1007/s00210-022-02320-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Kayki-Mutlu, Gizem
Aksoyalp, Zinnet Sevval
Wojnowski, Leszek
Michel, Martin C.
Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
title Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
title_full Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
title_fullStr Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
title_full_unstemmed Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
title_short Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
title_sort correction to: a year in pharmacology: new drugs approved by the us food and drug administration in 2021
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832083/
https://www.ncbi.nlm.nih.gov/pubmed/36335284
http://dx.doi.org/10.1007/s00210-022-02320-5
work_keys_str_mv AT kaykimutlugizem correctiontoayearinpharmacologynewdrugsapprovedbytheusfoodanddrugadministrationin2021
AT aksoyalpzinnetsevval correctiontoayearinpharmacologynewdrugsapprovedbytheusfoodanddrugadministrationin2021
AT wojnowskileszek correctiontoayearinpharmacologynewdrugsapprovedbytheusfoodanddrugadministrationin2021
AT michelmartinc correctiontoayearinpharmacologynewdrugsapprovedbytheusfoodanddrugadministrationin2021